Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00872
|
|||||
| Drug Name |
Zafirlukast
|
|||||
| Synonyms |
4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; 4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide; Accolate; Accolate (TN); Accolate, Accoleit, Vanticon, Zafirlukast; Accoleit; Accoleit (TN); Aeronix; AstraZeneca brand of zafirlukast; Carbamic acid, (3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl ester; Cyclopentyl (1-methyl-3-{[2-(methyloxy)-4-({[(2-methylphenyl)sulfonyl]amino}carbonyl)phenyl]methyl}-1H-indol-5-yl)carbamate; Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate; Cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate; Cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate; Cyclopentyl [3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate; Menarini brand of zafirlukast; Novartis brand of zafirlukast; Olmoran; Respix; Vanticon (TN); Zafirlukast (JAN/USAN/INN); Zafirlukast [USAN:BAN:INN]; Zafirst; Zeneca brand of zafirkulast
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antiasthmatic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C31H33N3O6S
|
|||||
| Canonical SMILES |
CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
|
|||||
| InChI |
InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)
|
|||||
| InChIKey |
YEEZWCHGZNKEEK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 107753-78-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 575.7 | Topological Polar Surface Area | 124 | ||
| Heavy Atom Count | 41 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
5.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:10100
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.